Racial/ethnic disparities in HIV infection among people who inject drugs: An international systematic review and meta-analysis

Addiction

Volumn 107, Issue 12, 2012, Pages 2087-2095

  Des Jarlais, Don C ^a   Bramson, Heidi A ^a   Wong, Cherise ^a   Gostnell, Karla ^a   Cepeda, Javier ^b   Arasteh, Kamyar ^a   Hagan, Holly ^a  

^a NEW YORK UNIVERSITY   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

HIV AIDS; Injection drug use; Injection drug users (IDU); International; Meta analysis; People who inject drugs (PWID); Racial ethnic disparities; Systematic review

Indexed keywords

ETHNIC GROUP; ETHNOLOGY; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; MINORITY GROUP; PREVALENCE; RACE; REVIEW; STATISTICS; SUBSTANCE ABUSE;

CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; HIV INFECTIONS; HUMANS; MINORITY GROUPS; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; WORLD HEALTH;

EID: 84869866373     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04027.x     Document Type: Review

References (45)

1. Le Cook B., McGuire T. G., Zuvekas S. H. Measuring trends in racial/ethnic health care disparities. Med Care Res Rev 2009; 66: 23-48.
2. US Department of Health and Human Services. HHS action plan to reduce racial and ethnic health disparities: a nation free of disparities in health and health care. Washington, DC: Department of Health and Human Services; 2011.
3. World Health Organization. Health and Freedom from Discrimination. Geneva: World Health Organization, Development Doha; 2001.
4. National Institutes of Health (NIH). NIH policy on reporting race and ethnicity data: subjects in clinical research. Report no.: NOT-OD-01-053. Bethesda, MD: NIH; 2001.
5. Needle R. H., Trotter R. T. II, Singer M., Bates C., Page J. B., Metzger D. etal. Rapid assessment of the HIV/AIDS crisis in racial and ethnic minority communities: an approach for timely community interventions. Am J Public Health 2003; 93: 970-979.
6. Ruan Y. H., Hong K. X., Liu S. Z., He Y. X., Zhou F., Qin G. M. etal. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol 2004; 10: 1589-1593.
7. Joint United Nations Programme on HIV/AIDS (UNAIDS). Special theme: the Millennium Development Goals and indigenous peoples: redefining the Goals. New York: UNAIDS Economic and Social Council's Permanent Forum on Indigenous Issues, 15-26 May; 2006.
8. Ali S. H. Stigmatized ethnicity, public health, and globalization. Can Ethn Stud 2008; 40: 43-64.
9. Latkin C., Srikrishnan A. K., Yang C., Johnson S., Solomon S. S., Kumar S. etal. The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug Alcohol Depend 2010; 110: 221-227.
10. Parker R., Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med 2003; 57: 13-24.
11. Rudolph A. E., Davis W. W., Quan V. M., Ha T. V., Minh N. L., Gregowski A. etal. Perceptions of community- and family-level injection drug user (IDU)- and HIV-related stigma, disclosure decisions and experiences with layered stigma among HIV-positive IDUs in Vietnam. AIDS Care 2012; 24: 239-244.
12. Valdiserri R. O. HIV/AIDS stigma: an impediment to public health. Am J Public Health 2002; 92: 341-342.
13. Ahern J., Stuber J., Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend 2007; 88: 188-196.
14. Braine N., Des Jarlais D. C., Goldblatt C., Zadoretzky C., Turner C. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. AIDS Educ Prev 2005; 17: 515-524.
15. Ksobiech K. Beyond needle sharing: meta-analyses of social context risk behaviors of injection drug users attending needle exchange programs. Subst Use Misuse 2006; 41: 1379-1394.
16. Fountain J., Bashford J., Underwood S., Khurana J., Winters M., Carpentier C. etal. Drug use amongst black and minority ethnic communities in the European Union and Norway. Probat J 2004; 51: 362-378.
17. Spicer N., Harmer A., Aleshkina J., Bogdan D., Chkhatarashvili K., Murzalieva G. etal. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments. Soc Sci Med 2011; 73: 1748-1755.
18. Anderson W. The New York Needle Trial: the politics of public health in the age of AIDS. Am J Public Health 1991; 81: 1506-1517.
19. Hallfors D. D., Iritani B. J., Miller W. C., Bauer D. J. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health 2007; 97: 125-132.
20. Halpern C. T., Hallfors D., Bauer D. J., Iritani B., Waller M. W., Cho H. etal. Implications of racial and gender differences in patterns of adolescent risk behavior for HIV and other sexually transmitted diseases [Comparative Study Research Support, NIH, Extramural Research Support, US Government Public Health Service]. Perspect Sex Reprod Health 2004; 36: 239-247.
21. Harawa N. T., Greenland S., Bingham T. A., Johnson D. F., Cochran S. D., Cunningham W. E. etal. Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States [Comparative Study Research Support, NIH, Extramural Research Support, US Government Public Health Service]. J Acquir Immune Defic Syndr 2004; 35: 526-536.
22. Koblin B. A., McCusker J., Lewis B. F., Sullivan J. L. Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study [Comparative Study Research Support, non-US Government]. Am J Epidemiol 1990; 132: 837-846.
23. Adimora A. A., Schoenbach V. J. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis 2005; 191: S115-122.
24. Des Jarlais D. C., Wenston J., Friedman S. R., Sotheran J. L., Maslansky R., Marmor M. Crack cocaine use in a cohort of methadone maintenance patients. J Subst Abuse Treat 1992; 9: 319-325.
25. Edlin B. R., Irwin K. L., Faruque S., McCoy C. B., Word C., Serrano Y. etal. Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team [see comment] [Multicenter Study Research Support, US Government Public Health Service]. N Engl J Med 1994; 331: 1422-1427.
26. Li X., Wang H., He G., Fennie K., Williams A. B. Shadow on my heart: a culturally grounded concept of HIV stigma among Chinese injection drug users. J Assoc Nurses AIDS Care 2012; 23: 52-62.
27. Cooper H. M., Hedges L. V. The Handbook of Research Synthesis. New York: Russell Sage Foundation; 1994.
28. Moher D., Liberati A., Tetzlaff J., Altman D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
29. Stroup D. F., Berlin J. A., Morton S. C., Olkin I., Williamson G. D., Rennie D. etal. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-2012.
30. Hagan H., Pouget E. R., Des Jarlais D. C., Lelutiu-Weinberger C. Meta-regression of hepatitis C Virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol 2008; 168: 1099-1109.
31. Stern R., Hagan H., Lelutiu-Weinberger C., Des Jarlais D., Scheinmann R., Strauss S. etal. The HCV Synthesis Project: scope, methodology, and preliminary results. BMC Med Res Methodol 2008; 8: 62.
32. StataCorp. Stata statistical software: release 11. College Station, TX: StataCorp LP; 2009.
33. Dekking F. M., Kraaikamp C., Lopuhaa H. P., Meester L. E. A Modern Introduction to Probability and Statistics: Understanding Why and How. London: Springer-Verlag; 2005, p. 207.
34. Goertzel T. The Myth of the Bell Curve. 1996. Available at: http://crab.rutgers.edu/~goertzel/normalcurve.htm (accessed 1 November 2011) (Archived by WebCite® at http://www.webcitation.org/69nfjJ8DJ on 9 August 2012).
35. Goertzel T., Fashing J. The myth of the normal curve: a theoretical critique and examination of its role in teaching and research. Humanity Soc 1981; 5: 14-31.
36. Nielsen S. S., Krasnik A. Poorer self-perceived health among migrants and ethnic minorities versus the majority population in Europe: a systematic review. Int J Public Health 2010; 55: 357-371.
37. Williams D. R., Jackson P. B. Social sources of racial disparities in health. Health Aff (Millwood) 2005; 24: 325-334.
38. Williams D. R., Mohammed S. A., Leavell J., Collins C. Race, socioeconomic status, and health: complexities, ongoing challenges, and research opportunities. Ann NY Acad Sci 2010; 1186: 69-101.
39. Saxe L., Kadushin C., Beveridge A., Livert D., Tighe E., Rindskopf D. etal. The visibility of illicit drugs: implications for community-based drug control strategies. Am J Public Health 2001; 91: 1987-1994.
40. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2011. Report no.: E.11.XI.10. Geneva: United Nations Publications; 2011.
41. Jia Y., Lu F., Zeng G., Sun X., Xiao Y., Lu L. etal. Predictors of HIV infection and prevalence for syphilis infection among injection drug users in China: community-based surveys along major drug trafficking routes. Harm Reduct J 2008; 5: 29.
42. Beyrer C., Razak M. H., Lisam K., Chen J., Lui W., Yu X. F. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000; 14: 75-83.
43. Rhodes T., Stimson G. V., Crofts N., Ball A., Dehne K., Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS 1999; 13: S259-269.
44. Friedman S. R., Curtis R., Neaigus A., Jose B., Des Jarlais D. C. Social Networks, Drug Injectors' Lives and HIV/AIDS. New York: Kluwer Plenum Academic Publishers; 1999.
45. United Nations Programme on HIV/AIDS, United Nations Office on Drugs and Crime, World Health Organization (UNAIDS, UNODC, WHO). WHO, UNODC, UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: UNAIDS, UNODC, WHO; 2009.